CNBC's Final Trades: ChargePoint Holdings, Energy Puts, And These Pharma And Health Care Stocks To Buy


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE:ZTS) is a pharma company “without all the problems that come with traditional pharmaceutical companies,” like generic competition and dealing with Medicare or insurance.

Joshua Brown of Ritholtz Wealth Management stated that ChargePoint Holdings Inc (NYSE:CHPT) “increasingly looks like it bottomed in early May.” He added that the stock is “very resilient.”

Check out other stocks making moves in the premarket.

Jim Lebenthal of Cerity Partners said Thermo Fisher Scientific Inc. (NYSE:TMO) is a “great health care company. Lebenthal added that he was recommending this stock as “we’re stuck right now while we wait for more information on inflation and earnings.”

Pete Najarian mentioned that there’s been a pullback in the energy space and there are a lot of put buyers. Energy Select Sector SPDR Fund (NYSE:XLE) has bought 68,000 of the October 52 puts, he added.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Long IdeasShort IdeasOptionsMarketsMediaTrading IdeasBrenda VingielloCerity PartnersCNBCJim LebenthalJoshua BrownPete NajarianRitholtz Wealth ManagementSand Hill Global Advisors